1,25-dyhydroxyvitamin D3 Attenuates l-DOPA-Induced Neurotoxicity in Neural Stem Cells
- 437 Downloads
The neurotoxicity of levodopa (l-DOPA) on neural stem cells (NSCs) and treatment strategies to protect NSCs from this neurotoxicity remain to be elucidated. Recently, an active form of vitamin D3 has been reported to display neuroprotective properties. Therefore, we investigated the protective effect of 1,25-dyhydroxyvitamin D3 (calcitriol) on l-DOPA-induced NSC injury. We measured cell viability via the cell counting kit-8 (CCK-8) and lactate dehydrogenase (LDH) assays and Annexin V/PI staining followed by flow cytometry, cell proliferation using the BrdU and colony-forming unit (CFU) assays, cell differentiation via immunocytochemistry, the levels of free radicals via 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) staining, apoptosis via DAPI and TUNEL staining, and intracellular signaling protein expression via Western blot. Antibody microarrays were also employed to detect changes in the expression of prosurvival- and death-related proteins. Treatment of NSCs with l-DOPA reduced their viability and proliferation. This treatment also increased the levels of free radicals and decreased the expression levels of intracellular signaling proteins that are associated with cell survival. However, simultaneous exposure to calcitriol significantly reduced these effects. The calcitriol-mediated protection against l-DOPA toxicity was blocked by the phosphoinositide 3-kinase (PI3K) inhibitor LY294004. l-DOPA also inhibited the expression of Nestin and Ki-67, and co-treatment with calcitriol alleviated these effects. The expression levels of GFAP, DCX, and Tuj1 were not significantly affected by treatment with l-DOPA or calcitriol. Calcitriol protects against l-DOPA-induced NSC injury by promoting prosurvival signaling, including activation of the PI3K pathway, and reducing oxidative stress.
Keywordsl-DOPA Neural stem cells 1,25-dyhydroxyvitamin D3 Neuroprotection
This work was supported by the NanoBio R&D Program of the Korea Science and Engineering Foundation, the Ministry of Education, Science, and Technology (2007–04717), and the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A101712).
Conflict of Interest
The authors declare that they have no conflicts of interest.
- 6.Müller T, Hefter H, Hueber R, Jost W, Leenders K, Odin P, Schwarz J (2004) Is levodopa toxic? J Neurol 251(6):vi44–vi46Google Scholar
- 16.Arias-Carrión O, Yamada E, Freundlieb N, Djufri M, Maurer L, Hermanns G, Ipach B, Chiu W-H, Steiner C, Oertel W, Höglinger G (2009) Neurogenesis in substantia nigra of parkinsonian brains? In: Giovanni G, Di Matteo V, Esposito E (eds) Birth, life and death of dopaminergic neurons in the substantia nigra, vol 73. J Neural Transm. Supplementa. Springer Vienna, pp 279–285Google Scholar
- 19.Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen E-Y, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Déglon N, Aebischer P (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 290(5492):767–773PubMedCrossRefGoogle Scholar
- 26.Taniura H, Ito M, Sanada N, Kuramoto N, Ohno Y, Nakamichi N, Yoneda Y (2006) Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 83(7):1179–1189PubMedCrossRefGoogle Scholar
- 39.Gerlach M, Braak H, Hartmann A, Jost WH, Odin P, Priller J, Schwarz J (2002) Current state of stem cell research for the treatment of Parkinson’s disease. J Neurol 249(3):iii33–ii35Google Scholar
- 50.Kriebitzsch C, Verlinden L, Eelen G, van Schoor NM, Swart K, Lips P, Meyer MB, Pike JW, Boonen S, Carlberg C, Vitvitsky V, Bouillon R, Banerjee R, Verstuyf A (2011) 1,25-dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase. J Bone Miner Res 26(12):2991–3000PubMedCentralPubMedCrossRefGoogle Scholar
- 55.Klotz B, Mentrup B, Regensburger M, Zeck S, Schneidereit J, Schupp N, Linden C, Merz C, Ebert R, Jakob F (2012) 1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. PLoS One 7(1):e29959PubMedCentralPubMedCrossRefGoogle Scholar
- 56.Höhler B, Lange B, Holzapfel B, Goldenberg A, Hänze J, Sell A, Testan H, Möller W, Kummer W (1999) Hypoxic upregulation of tyrosine hydroxylase gene expression is paralleled, but not induced, by increased generation of reactive oxygen species in PC12 cells. FEBS Lett 457(1):53–56PubMedCrossRefGoogle Scholar
- 60.de Groot MWGDM, Westerink RHS Chemically-induced oxidative stress increases the vulnerability of PC12 cells to rotenone-induced toxicity. NeuroToxicology (0)Google Scholar